Evaluation of FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: Design and rationale of the EFFORTLESS S-ICD registry

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 5, 2012, Pages 574-579

  Pedersen, Susanne S ^a,b   Lambiase, Pier ^c   Boersma, Lucas V A ^d   Murgatroyd, Francis ^e   Johansen, Jens Brock ^f   Reeve, Helen ^g   Stuart, A Graham ^h   Adragao, Pedro ⁱ   Theuns, Dominic A M J ^b  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g Cameron Health BV   (Netherlands)

^h BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

ⁱ HOSPITAL DE SANTA CRUZ   (Portugal)

Author keywords

implantable cardioverter defibrillator; physician survey; quality of life; registry; subcutaneous

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; EUROPE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; NEW ZEALAND; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; REGISTER; RETROSPECTIVE STUDY; STUDY DESIGN; SUPRAVENTRICULAR TACHYCARDIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EUROPE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT SATISFACTION; QUALITY OF LIFE; REGISTRIES; RESEARCH DESIGN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860834028     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03337.x     Document Type: Article

References (26)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
3. Tung R, Zimetbaum P, Josephson ME,. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008; 52: 1111-1121.
4. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW,. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 47: 2493-2497.
5. Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM,. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction. Europace 2010; 12: 395-401.
6. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, et al,. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007; 115: 2474-2480.
7. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns DAMJ, et al,. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010; 363: 36-44.
8. McLeod KA, McLean A,. Implantation of a fully subcutaneous ICD in children. Pacing Clin Electrophysiol 2012; 35: e20-03.
9. Sears SF, Kirian K,. Shock and patient-centered outcomes research: Is an ICD shock still a critical event Pacing Clin Electrophysiol 2010; 33: 1437-1441.
10. Dabiri Abkenari L, Theuns DAMJ, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, et al,. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol 2011; 100: 737-744.
11. The Institute of Medicine. Crossing the quality chasm: A New Health System for the 21st Century. Washington, DC, National Academy Press, 2001.
12. Cannom DS, Fisher J,. The Fidelis recall: How much pressure can the ICD world bear Pacing Clin Electrophysiol 2008; 31: 1233-1235.
13. Matlock DD,. Big brother is watching you: What do patients think about ICD home monitoring Circulation 2010; 122: 319-321.
14. Ware JJ, Kosinski M, Keller SD,. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
15. EuroQol: Group. Euroqol: A new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
16. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
17. Bjelland I, Dahl AA, Haug TT, Neckelmann D,. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
18. Denollet J,. DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005; 67: 89-97.
19. Denollet J, Schiffer A, Spek V,. A general propensity to psychological distress affects cardiovascular outcomes: Evidence from research on the Type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 2010; 3: 546-557.
20. Pedersen SS, van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RAM,. Concerns about the implantable cardioverter defibrillator: A determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 2005; 149: 664-669.
21. Pedersen SS, van den Broek KC, Erdman RAM, Jordaens L, Theuns DAMJ,. Pre implantation ICD concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 2010; 12: 1446-1452.
22. Burns JL, Serber ER, Keim S, Sears SF,. Measuring patient acceptance of implantable cardiac device therapy: Initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol 2005; 16: 384-390.
23. Pedersen SS, Spindler H, Johansen JB, Mortensen PT, Sears SF,. Correlates of patient acceptance of the cardioverter defibrillator: Cross-validation of the Florida Patient Acceptance Survey in Danish patients. Pacing Clin Electrophysiol 2008; 31: 1168-1177.
24. Hevey D, McGee HM, Horgan J,. Responsiveness of health-related quality of life outcome measures in cardiac rehabilitation: Comparison of cardiac rehabilitation outcome measures. J Consult Clin Psychol 2004; 72: 1175-1180.
25. Pedersen SS, Theuns DAMJ, Muskens-Heemskerk A, Erdman RAM, Jordaens L,. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace 2007; 9: 675-680.
26. van den Broek KC, Nyklicek I, van der Voort PH, Alings M, Meijer A, Denollet J,. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J Am Coll Cardiol 2009; 54: 531-537.